Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals

REGN

#232

Rank

A$123.98 B

Marketcap

🇺🇸 United States

Country

$1,128

Share price

-0.87%

Change (1 day)

-6.99%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Regeneron Pharmaceuticals - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year	Net assets	Change
2023-12-31	$A$38.12 B	14.47%
2022-12-31	$A$33.30 B	28.65%
2021-12-31	$A$25.88 B	80.55%
2020-12-31	$A$14.33 B	-9.47%
2019-12-31	$A$15.83 B	27.42%
2018-12-31	$A$12.43 B	57.95%
2017-12-31	$A$7.86 B	27.5%
2016-12-31	$A$6.17 B	23.03%
2015-12-31	$A$5.01 B	61%
2014-12-31	$A$3.11 B	42.39%
2013-12-31	$A$2.18 B	82.61%
2012-12-31	$A$1.19 B	152.98%
2011-12-31	$A$0.47 B	-8.83%
2010-12-31	$A$0.51 B	17.65%
2009-12-31	$A$0.44 B	-26.07%
2008-12-31	$A$0.59 B	13.49%
2007-12-31	$A$0.52 B	91.58%
2006-12-31	$A$0.27 B	76.37%
2005-12-31	$A$0.15 B	-33.95%
2004-12-31	$A$0.23 B	27.39%
2003-12-31	$A$0.18 B	-28.53%
2002-12-31	$A$0.25 B	-50.35%
2001-12-31	$A$0.52 B

Net assets for similar companies or competitors

Company	Net assets	differencediff.	Country
Amgen AMGN	A$11.50 B	-74.33%	🇺🇸 USA
Alnylam Pharmaceuticals ALNY	A$49.46 M	-99.89%	🇺🇸 USA
Biogen BIIB	A$25.00 B	-44.22%	🇺🇸 USA
Johnson & Johnson JNJ	A$107.25 B	139.24%	🇺🇸 USA
Novartis NVS	A$66.41 B	48.13%	🇨🇭 Switzerland
Sanofi SNY	A$119.63 B	166.83%	🇫🇷 France

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Regeneron Pharmaceuticals (REGN) - Net assets

Net assets on the balance sheet as of September 2024 : A$44.83 Billion